Evidence map›Paper›PMID 21536841›Full record

ReviewThe Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry2012

Unwrapping myelination by microRNAs.

Xuelian He, Yang Yu, Rajeshwar Awatramani, Q Richard Lu

Open access · greenAbstract readReview
In one paragraph

Review in The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Exosomes in stroke pathogenesis and therapy.The Journal of clinical investigation · 2016
    Review
  12. Remyelinating Oligodendrocyte Precursor Cell miRNAs from the Sfmbt2 Cluster Promote Cell Cycle Arrest and Differentiation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  13. How to make an oligodendrocyte.Development (Cambridge, England) · 2015
    Review
  14. Article
  15. Article
  16. Article
  17. Promoting brain remodeling to aid in stroke recovery.Trends in molecular medicine · 2015
    Review
  18. Review
  19. Nanofiber-mediated microRNA delivery to enhance differentiation and maturation of oligodendroglial precursor cells.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Article
  20. The role of exosomes in peripheral nerve regeneration.Neural regeneration research · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Xuelian HeInstitute of Stem Cell & Developmental Biology, West China Second Hospital, Sichuan University, Chengdu, PR China.
Yang Yu
Rajeshwar Awatramani
Q Richard Lu
Foundation Center · USNorthwestern University · US

Funding

Molecular Mechanisms of Oligodendrocyte Differentiation and MyelinationR01NS072427 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2010 to 2018
$3.6M
Chromatin remodeling control of myelination and remyelinationR01NS075243 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2012 to 2018
$2.6M
Olig2 in Oligodendrocyte Myelination and RemyelinationR01NS050389 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI LU, QING R · 2005 to 2009
$1.8M
The role of microRNAs in peripheral myelin formation and maintenanceR21NS063138 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI AWATRAMANI, RAJESHWAR B · 2008 to 2009
$363k
NINDS NIH HHS NS050389NINDS NIH HHS R01 NS050389NINDS NIH HHS R01 NS072427NINDS NIH HHS R01 NS075243NINDS NIH HHS R21 NS063138NINDS NIH HHS R21NS063138
6 · The paper itself

Abstract

Myelination of axons by oligodendrocytes and Schwann cells in the central and peripheral nervous system, respectively, is essential for normal neuronal functions, and its failure results in devastating demyelinating diseases. During development, both oligodendrocyte and Schwann cell precursors undergo a temporally well-defined series of molecular and structural changes, ultimately culminating in the cessation of proliferation and the elaboration of a highly complex myelin sheath. Recent studies have demonstrated a critical role of microRNAs (miRNAs) in the progression of oligodendrocyte and Schwann cell precursors to the myelinating state-depletion of miRNAs from either cell type results in an arrest in differentiation and lack of myelination. Furthermore, these studies have begun to elucidate the dynamic regulation of miRNA expression and the complexity of miRNA-mediated gene regulation during differentiation of myelinating cells. In this review, the authors highlight the recent understanding of functional links of miRNAs to regulatory networks for central and peripheral myelination, as well as perspectives on the role of miRNAs in demyelinating diseases.

Indexed as

AnimalsAstrocytesAxonsCell DifferentiationDemyelinating DiseasesGene Expression RegulationHumansMiceMice, KnockoutMicroRNAsMyelin SheathNeuronsOligodendrogliaSchwann CellsMicroRNAs

Identifiers

PMID21536841
PMCPMC3551447
OpenAlexW1981046952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.